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A B S T R A C T
Aim: In previous studies, upregulation of NOS during acclimatization of rats to sustained hypobaric hypoxia was
associated to cardioprotection, evaluated as an increased tolerance of myocardium to hypoxia/reoxygenation.
The objective of the present work was to investigate the effect of acute hypobaric hypoxia and the role of
endogenous NO concerning cardiac tolerance to hypoxia/reoxygenation under β-adrenergic stimulation.
Methods: Rats were submitted to 58.7 kPa in a hypopressure chamber for 48 h whereas their normoxic controls
remained at 101.3 kPa. By adding NOS substrate L-arg, or blocker L-NNA, isometric mechanical activity of
papillary muscles isolated from left ventricle was evaluated at maximal or minimal production of NO, respec-
tively, under β-adrenergic stimulation by isoproterenol, followed by 60/30min of hypoxia/reoxygenation.
Activities of NOS and cytochrome oxidase were evaluated by spectrophotometric methods and expression of
HIF1-α and NOS isoforms by western blot. Eosin and hematoxiline staining were used for histological studies.
Results: Cytosolic expression of HIF1-α, nNOS and eNOS, and NO production were higher in left ventricle of
hypoxic rats. Mitochondrial cytochrome oxidase activity was decreased by hypobaric hypoxia and this effect was
reversed by L-NNA. After H/R, recovery of developed tension in papillary muscles from normoxic rats was
51–60% (regardless NO modulation) while in hypobaric hypoxia was 70% ± 3 (L-arg) and 54% ± 1 (L-NNA).
Other mechanical parameters showed similar results. Preserved histological architecture was observed only in L-
arg papillary muscles of hypoxic rats.
Conclusion: Exposure of rats to hypobaric hypoxia for only 2 days increased NO synthesis leading to cardio-
protection.
1. Introduction
Hypoxic states of the cardiovascular system are undoubtedly asso-
ciated with the most frequent diseases of modern times. Reduced
oxygen supply with adequate perfusion to the myocardium can be ob-
served in diverse conditions, such as cor pulmonale, congenital heart
disease, and high altitudes. In the myocardium of subjects living per-
manently at high altitudes, systemic hypoxia can be qualified as phy-
siological [1–3].
In our laboratory, a model of sustained hypobaric hypoxia which
simulates high altitude hypoxia under environmental and hereditary
controlled conditions has been developed [4–6]. Results showed that
acclimatization to simulated altitude delayed the age-associated decline
in the functional capacity of rat myocardium and improved its recovery
after hypoxia and reoxygenation, determined in isolated papillary
muscle from the left ventricle [2]. Cardioprotection conferred by our
model lasted markedly longer, following removal of the stimulus than
that achieved by the thoroughly studied phenomenon of ischemic
preconditioning [7], intermittent hypobaric hypoxia [8] or pharmaco-
logical treatments. The cardioprotective effects presented a linear de-
cline during deacclimatization, with mean half-time of 5.5 months (mo)
for the total normalization of the response, persisting even after the
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regression of other hypoxia-induced changes such as polycythemia,
pulmonary hypertension and right ventricle hypertrophy [9]. Indeed,
resistance to myocardial ischemia was increased in rabbits raised from
birth to 10 days of age in a hypoxic (12% O2) environment [10].
Moreover, isolated hearts from mice submitted to 10% O2 for 4 h were
resistant to infarction 24 h later [11]. In both cases the effect was as-
sociated to an enhanced cytosolic NOS activity. The duration, fre-
quency, and severity of hypoxic episodes become critical factors de-
termining whether hypoxia could be harmful [12], or paradoxically
beneficial [2,3,13].
Endogenous NO plays a fundamental role in protecting the heart
against both reversible (myocardial stunning) and irreversible (myo-
cardial infarction) ischemia/reperfusion injury [3,14]. The three main
isoforms of NO synthase, namely, neuronal NOS (nNOS), endothelial
NOS (eNOS), and the inducible NOS (iNOS), were reported to be in-
volved in cardioprotection by systemic acute and chronic hypoxia
[11,15–17]. During acclimatization to sustained hypobaric hypoxia, an
increased NOS protein expression in mitochondrial fraction of left
ventricle was associated to the preservation of papillary muscle con-
tractile parameters and tolerance to O2 deprivation [2,13], whereas
during deacclimatization the normalization time of NOS activity and
expression paralleled the decline in the cardioprotective effects [9]. NO
effects depend, among others, on NO concentration [9], compartmen-
talization of NOS enzymes and local redox conditions of cells and tis-
sues [14].
Many evidences collected by both in vivo and in vitro experiments
suggest a crosstalk between NO and adrenergic receptors [18–20]. In
vascular endothelial cells NO generated by eNOS acts a signaling mo-
lecule and one of its main functions is to cause vasodilatation via cGMP,
whereas stimulation of β-adrenergic receptors increases vascular tone
via cAMP. Both important cell-signaling systems play a role in mod-
ulation of contractility and are interconnected, being NO production
directly linked to stimulation of β-adrenoceptors in many instances
[18,21]. Within the myofibrils or the myocytes of the ventricular wall,
contractility is mainly modulated by intracellular transient Ca2+
availability, which is increased by both the β-adrenergic and the NO
generated by nNOS systems [22], stimulating the opening of L and RyR
Ca2+ channels through phosphorylation and nitrosylation, respectively
[14,23]. Furthermore, NO inhibits cytochrome oxidase, modulating
ATP availability for contractility [9,24]. On the other hand, the β-
adrenergic system, which contributes to regulate the blood pressure,
has been implicated in a cardioprotective model when has been sti-
mulated [25,26]. This topic seems to be important, because many
cardiac patients are treated with β-blockers to control the arterial
pressure, which is often increased by exposure to hypoxic hypobaric
environment [27,28].
The aim of the present study was to evaluate the effect of acute
hypobaric hypoxia (HH) and the role of endogenous NO in the mod-
ulation of cardiac β-adrenergic stimulation and tolerance to hypoxia/
reoxygenation (H/R). For this purpose, in papillary muscles (PM) from
left ventricles of rats submitted to HH, mechanical activity was se-
quentially determined under basal conditions, and at maximal and
minimal production of NO in response to β-adrenergic stimulation and
during H/R. Furthermore, left ventricle (LV) cytosolic NOS expression
and activity, HIF-1α expression, histological status and blood pressure
were evaluated.
2. Methods
2.1. Experimental design
Three mo-old male Wistar rats of the CHbbTHOM albino strain
(n=10) were submitted during 48 h to a simulated altitude of 4400m
(58.7 kPa=440mmHg) in a hypopressure chamber as previously de-
scribed [29], whereas the same number of sibling rats (n=10) re-
mained as controls at sea level atmospheric pressure
(101.3 kPa=760mmHg). Food and water were administered ad-li-
bitum. Pressure changes were achieved slowly, and the renewal of air in
the chamber was sufficient to ensure the composition of atmospheric
air. The partial pressure of O2 in the inspired air was, therefore,
12.3 kPa=92mmHg and 21.2 kPa= 159mmHg, for hypoxic and
control rats, respectively. Both groups were maintained at the same
temperature (22 °C) on a schedule of 12 h of light and 12 h of dark.
Systolic blood pressure was recorded before and after the hypobaric
exposure in a similar group of awake rats at 30 °C by tail plethysmo-
graphy, using a NIBP controller module in conjunction with a Power
Lab system (AD Instruments, USA). Recordings were stored and ana-
lyzed using Lab Chart software (AD Instruments). Rats received care in
accordance with the 6344/96 regulation of the Argentinean National
Drug, Food, and Medical Technology Administration (ANMAT) and the
study was carried out in accordance with the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of Laboratory
Animal Research and published by the National Institutes of Health
(NIH Publications No. 8023, revised 1978).
2.2. Heart muscle preparations
Immediately after removing hypoxic rats from the hypobaric
chamber as well as in controls, the thorax was opened under anesthesia
with penthobarbital overdose of 60mg/kg, the heart was excised,
rinsed and transferred to Ringer solution of the following composition
(in mM): 128.3 NaCl, 4.7 KCl, 20.2 NaHCO3, 0.35 NaH2PO4, 1.05
MgSO4, 1.35 CaCl2, and 5.5 glucose, pH 7.4, flushed with 95% O2–5%
CO2, at 30 °C. The left ventricle was opened, and both papillary muscles
were removed while submerged in buffer. The chordae end of each
muscle was tied with 10-0 nylon suture, which was attached to a
Statham force transducer and 9853 coupler (Gould-Statham) mounted
on a movable support controlled by a micrometer for accurate length
adjustment. The bottom end of each papillary muscle was inserted into
a stainless steel spring clip, and the muscles were mounted vertically in
two temperature-controlled chambers containing 30ml of the Ringer
solution each one. The solutions were equilibrated with a mixture of
95% O2 and 5% CO2, with pH and temperature kept constant at 7.4 and
30 °C, respectively [22]. The heart, trimmed of atria and large vessels,
was dissected into the left ventricle plus septum (LV) and right ventricle
(RV), which were weighed separately [29].
2.3. Papillary muscle mechanical activity
Papillary muscles (total n= 40) were allowed to stabilize for 45min
after mounting. Rectangular pulses of 10ms with an amplitude 20%
higher than the threshold of each preparation were digitally delivered
by means of a stimulator controlled by a data acquisition and analysis
software (FPE). Contraction frequency was kept constant at 12 beats
min−1. The muscles were then stretched until maximal developed
tension occurred. The isometric mechanograms were recorded on a
Beckman R511A connected to the force transducer, and simultaneously
the computer utilizing FPE digitized and stored the force-pacing signal
for later analysis. Maximal developed tension (DT), maximal rate of rise
in DT (+T), and maximal velocity of relaxation (-T) were determined.
Each data result was the mean of three successive twitches (38). After
recording the basal contractility, papillary muscles (PM) were in-
cubated 10 min with 2 mM L-arg, a NOS substrate, to obtain the
maximal endogenous NO production or with 2 mM L-NNA, a NOS
blocker, to obtain the minimum production of endogenous NO. Controls
were performed at the same conditions but without NOS substrate or
blocker. The three subgroups were then β-adrenergic stimulated with
0.1 mM isoproterenol hydrochloride (ISO). A 60-min period of hypoxia
was then established by using a gas mixture of 95% N2 and 5% CO2,
followed by a 30-min period of reoxygenation (95% O2 and 5% CO2),
and mechanical events were recorded every 10min (Fig. 1). At the end
of each experiment, muscles length was measured with a caliper. The
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PM were then blotted dry and weighed, and cross-sectional area of each
one was calculated, assuming the muscle to be a cylinder with a density
of 1.0. Mechanical parameters were normalized for muscle cross-sec-
tional area [9].
2.4. Histological analysis
Once papillary muscles were removed, the remnant cardiac tissue
underwent formalin fixation. After inclusion in paraffin, the hearts were
cut horizontally into one central block between the base and apex. The
block was dehydrated through a graded series of ethanol solutions
(70–100%), cleaned with xylene at room temperature, and embedded
in paraffin at 60 °C for 2 h 3 times. Paraffin blocks were stored at 4 °C
until sectioning. For light microscopy, heart sections (3 μm thickness)
were prepared serially and stained with hematoxylin and eosin.
Histological changes of the whole heart and the papillary muscles were
observed under a light microscope to detect recent ischemic myocardial
changes. A Nikon Eclipse 50i microscope (Nikon Corporation, Tokyo,
Japan), equipped with a digital camera (Nikon Coolpix S4) and the
Image-Pro Plus image processing software version 6.0 (Media
Cybernetics, Silver Spring, Maryland, USA) were used.
2.5. Isolation of left ventricle cytosolic and mitochondrial fractions
Left ventricles deprived of the papillary muscles were weighed,
chopped, and homogenized in an ice-cold homogenization medium
(1:10) containing 0.23M mannitol, 0.07M sucrose, 10mM Tris-HCl,
and 1mM EDTA, pH 7.4, for 30 s with a blade homogenizer (Kendro-
Sorvall-Du Pont Institute, Asheville, NC) and by five strokes in a glass
Teflon homogenizer. All these operations were carried out at 2-4 °C. The
homogenates were centrifuged at 700 g for 10min to discard nuclei and
cell debris, and the supernatant was centrifuged at 8000 g for 10min.
The supernatant, containing the cytosolic fraction, was separated from
the mitochondrial pellet. Mitochondrial pellet was washed and re-
suspended in the same buffer at a protein concentration of 20–25mg/
ml. Submitochondrial membranes were obtained by twice freezing and
thawing the mitochondrial preparation and were homogenized by
passage through tuberculine syringe with a needle. Protein concentra-
tion was determined with the Folin reagent and bovine serum albumin
as standard.
2.6. Nitric oxide production
Production of NO was measured in cytosolic fractions from left
ventricles by following the oxidation of oxyhaemoglobin (HbO2) to
methaemoglobin (metHb) at 37 °C. The NO assay was performed using
a Beckman-Coulter Serie DU 7400 diode array spectrophotometer in
which the active wavelength is set at 577 nm and the reference wave-
length at the isosbestic point at 591 nm (ε=11.2mM−1 cm−1) [30].
The method is based on the original assay developed by Murphy and
Noack [29] for perfused organs in which the HbO2 γ band is used to
follow NO production. The α band is more suitable for high light
scattering conditions of cellular and mitochondrial suspensions due to
the close vicinity of the active (577 nm) and the reference (591 nm)
wavelengths [30]. The measurements were carried out in a reaction
medium containing 50mM phosphate buffer pH 7.4, 1 mM CaCl2,
50 μM L-arginine, 100 μM NADPH, 10 μM DTT, 4 μM Cu-Zn superoxide
dismutase (SOD), 0.1 μM catalase, cytosolic fractions (0.5–1.0mg pro-
tein/ml) and 25 μM oxyhaemoglobin (expressed per heme group).
Controls adding 0.5 mMNω-nitro-L-arginine (L-NNA) as NOS inhibitor
were performed in all cases to give specificity to the assay.
2.7. Expression of HIF-1α, eNOS and nNOS
Equal amounts of cytosolic protein (80 μg) or mitochondria (60 μg)
were loaded into SDS-PAGE (7.5% or 15%), separated and blotted onto
nitrocellulose membranes in Tris-glycine-MeOH buffer. Non-specific
binding was blocked by incubation of the membranes with 5% non-fat
dry milk in PBS for 1 h at room temperature. The blots were probed
with a dilution 1:500 of polyclonal primary antibodies specific for
nNOS (rabbit, amino terminus, H-299, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), eNOS (rabbit, amino terminus, N-20, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), VDAC (goat, N-18, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or β-tubulin (mouse): ab131205,
Abcam. Primary antibodies were incubated in 1% BSA in PBS overnight
at 4 °C with rocking. The blots were rinsed three times for 15min with
PBST (PBS with 0.15% Tween 20) and then incubated with horseradish
peroxidase-conjugated secondary antibodies (anti-rabbit or anti-goat)
at 1:5000 in 2.5% non-fat dry milk in PBS for 1 h at room temperature
with rocking. The blots were rinsed three times for 10min with PBS and
then exposed with ECL reagent. In the case of HIF, primary antibody
against HIF-1α (goat, C terminus, C-19, Santa Cruz Biotechnology,
Santa Cruz, CA, USA) in a dilution 1:500 was used. Biotin conjugated
secondary anti-goat (Code: RPN1025V, GE healthcare, Buckingham,
UK) and streptavidin-horse radish peroxidase complex (Code:
RPN1051, GE healthcare, Buckingham, UK) were used at 1:10000 di-
lution. Densitometric analysis of bands was performed using the NIH
Image 1.54 software. All experiments were performed in triplicate.
2.8. Cytochrome oxidase activity (complex IV) was assayed
spectrophotometrically at 550 nm by following the rate of oxidation of
reduced cytochrome c [13]
Cytochrome c was reduced with dithionite that was removed
afterwards by eluting through a Sephadex-G25 column with potassium
phosphate buffer (10mM), pH 7.4. The reaction was initiated by the
addition of 50 μM reduced cytochrome c to submitochondrial mem-
branes (0.5 mg/ml) and the rate of reduced cytochrome c oxidation was
determined as a pseudo-first-order reaction constant (k’) [expressed as
k’/mg protein].
2.9. Statistics
Results are expressed as mean values ± SE. One-way ANOVA plus
the post ANOVA Bonferroni t-test for multiple comparisons were used
for statistical analysis of the data as appropriate (Microcal Origin 6.0
statistical software). A value of p < .05 was considered statistically
significant.
Fig. 1. Experimental design. a: papillary muscles from normoxic
rats; b: papillary muscles from rats submitted 48 h to hypobaric
hypoxia. Control (n= 6), L-arg (n= 7), L-NNA (n= 7) in each
subgroup. ISO: 0.1mM isoproterenol; L-arg 2mM and L-NNA
2mM.
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3. Results
3.1. Biological parameters
After 48 h of exposure to 4400m simulated altitude body weight
was 7% lower, whereas ventricles weight, papillary muscles area and
arterial pressure were similar to the normoxic group (Table 1).
3.2. Expression of HIF-1α
Expression of HIF-1α was evaluated because of its relevance as
biochemical regulator of oxygen homeostasis increasing in acute hy-
poxia. After 48 h of hypobaric hypoxia the ratio of protein expression of
HIF-1α/β-tubulin was 32% higher in cytosolic left ventricles, as com-
pared with normoxic rats, p < .05 (Fig. 2).
3.3. Expression of NOS and NO production
In the conditions of the assay, the left ventricle cytosol from nor-
moxic and hypoxic groups reacted differentially with anti-eNOS, and
anti-nNOS antibodies. The densitometric quantification of the Western
Blot spots indicated a higher level of expression of cytosolic eNOS
(53%) and nNOS (76%) in the hypoxic group than in normoxic rats,
p < .05 (Fig. 3a). The rates of NO production were measured in cy-
tosolic fractions from left ventricles. In normoxic rats, production rate
was 0.28 ± 0.02 nmol NO min−1 mg protein−1. After 48 h of hypo-
baric hypoxia, cytosolic NO production was significantly increased
(32%) to 0.37 ± 0.04 nmol NO min−1 mg protein−1, p < .05 (Fig. 3
b). Mitochondrial expression shown as the ratio of densitometric units
NOS/VDAC tended to increase (11%) for nNOS in the hypoxic group
although this result was not statistically significant (N: 0.74 ± 0.03;
HH: 0.82 ± 0.08); eNOS expression was similar for both normoxic and
hypoxic groups (N: 0.86 ± 0.05, HH: 0.87 ± 0.10).
3.4. Cytochrome oxidase activity (complex IV)
In the normoxic group, mitochondrial cytochrome oxidase activity
was not significantly affected by the addition of NOS substrate L-arg or
inhibitor L-NNA. After 48 h of hypobaric hypoxia cytochrome oxidase
activity was 27% decreased in control conditions, while it was 24%
decreased in the presence of L-arg. These changes in cytochrome oxi-
dase activity in the hypoxic groups were abolished when the assay was
carried out in the presence of L-NNA (Fig. 4).
3.5. Basal contractile parameters and modulation by NO
The basal contractile parameters, developed tension and maximal
rates of contraction and relaxation, which in papillary muscles pre-
parations are vascular tone independent, were similar in rats exposed to
48 h of simulated high altitude than in those from normoxic animals
(Table 2) and were not affected by the addition of the substrate L-arg or
the NOS blocker L-NNA (data not shown).
3.6. Mechanical β–adrenergic response
The increase in the developed tension of the normoxic papillary
muscles in response to isoproterenol was: 48 ± 10%, 42 ± 8% and
47 ± 4%, for control, L-arg and L-NNA respectively (Fig. 5a). On the
contrary, the β–adrenergic response of papillary muscles from HH was
significantly higher when NOS substrate was added: 36 ± 4%,
64 ± 6%, and 46 ± 5% for C, L-arg and L-NNA, respectively (Fig. 5b).
Similar results were observed for the basal rates of contraction and
relaxation (Table 3).
3.7. Tolerance to hypoxia/reoxygenation
After a period of 60min of hypoxia and 30min of reoxygenation the
normoxic group recovered 51 ± 4%, 60 ± 1% and 57 ± 3% of DT in
control, L-arg and L-NNA, respectively, without significant differences
between treatments (Fig. 6a). In rats submitted to HH for 48 h the re-
covery after H/R was significantly higher than in normoxic rats whe-
ther in C (78 ± 6%) as in L-arg (70 ± 3%), and cardioprotection was
lost (Fig. 6b) with the addition of NOS blocker (54 ± 1%). Similar
results were observed for the rates of contraction and relaxation
(Table 4).
3.8. Histological analysis
Left ventricles of rats exposed to hypobaric hypoxia for 48 h pre-
sented slight modifications in their morphology when compared with
those of normoxic rats. In particular, some evidence of capillary con-
gestion in the hypoxic ventricle was observed (Fig. 7). No other re-
markable changes were found. Histopathology analysis was performed
in the papillary muscles which underwent the different specific treat-
ments previously described (Fig. 1). After H/R, the papillary muscles
from normoxic and hypoxic rats supplemented with an inhibitor of
NOS, L-NNA, presented characteristic histological features of ischemia
and muscle fiber stress: capillary congestion, edema, wavy myocardial
fibers, contraction bands, hypereosinophilia and myocyte nuclei loss
(Fig. 8, b and d). Papillary muscles of the normoxic group supple-
mented with L-arg showed evidence of cellular edema; in contrast,
those from rats exposed to hypobaric hypoxia for 48 h were preserved
when supplemented with L-arg (Fig. 8, a and c).
4. Discussion
We have previously reported that acclimatization of rats to sus-
tained hypobaric hypoxia retarded age-associated decline in left ven-
tricle mechanical activity and improved posthypoxic recovery, invol-
ving an increased NO production and NOS protein expression in
Table 1
Biological parameters of rats submitted 48 h to 58.7 kPa (HH) and of their controls at 101.3 kPa (N).
Group Body weight
(g)
Heart weight
(g)
Left ventricle weight (g) Right ventricle
weight (g)
Papillary muscle area (mm2) Arterial pressure
(mmHg)
N 457 ± 3 1.13 ± 0.06 0.89 ± 0.06 0.24 ± 0.06 1.2 ± 0.1 136 ± 2
HH 427 ± 9* 1.10 ± 0.06 0.90 ± 0.06 0.20 ± 0.06 1.2 ± 0.1 139 ± 2
Values are means ± SE; n= 10 rats in each group (20 papillary muscles). HH, rats submitted to 58.7 kPa, 48 h; N, controls at 101.3 kPa. *P < .05.
Fig. 2. Left ventricle cytosolic HIF-α1 expression. N: normoxic group; HH: hypobaric
hypoxia 48 h. Ratio HIF-1α/β-tubulin expressed in densitometric units. Paired t-test two-
tailed, *P < .05; SE of the difference= 0.12.
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mitochondrial fraction [2,9,13]. The present study shows that 48 h of
acute exposure of young adult rats to 4400m simulated altitude confers
cardioprotection with the participation of cytosolic NO.
4.1. Biological parameters
After 48 h of exposure of rats to 4400m simulated altitude the body
weight decreased 7%. The weight loss has been associated to the HIF
[1,31], throughout a variation in the leptin levels, which impacts as a
decrease of food intake, with a marked reduction in fat content [32,33].
Contradictory data on blood pressure changes at high altitude has been
reported. In fact, while some authors described an increase in systemic
blood pressure, others found no significant changes [34,35] as in our
study. Increased arterial pressure after ascent to a similar high altitude
in humans has been reported to the point that the use of β-blockers for
sojourner travelers was recommended [27,36]. The species and proto-
cols used could explain the different observations [23,37]. In humans,
the climbing time, the low temperature, and psychophysical stress can
stimulate the sympathetic nervous system [35,38], whereas in our
Fig. 3. (a) Left ventricle cytosolic NOS expres-
sion; (b) Left ventricle cytosolic NOS production.
N: normoxic group; HH: hypobaric hypoxia 48 h;
ratio NOS/β-Tubulin expressed in densitometric
units. Values are means ± SE; *P < .05 vs. N
group.
Fig. 4. Cytochrome oxidase activity evaluated in left ventricle mitochondria under con-
ditions of maximal NO production (in the presence of L-arg), minimal NO production (in
the presence of L-NNA) and control NO production (with no additions). Values are
means ± SE; *P < .05 vs. all groups.
Table 2
Basal contractile parameters of papillary muscles from rats submitted 48 h to 58.7 kPa
(HH) and from their controls at 101.3 kPa (N).
Group Developed tension
g.mm−2
Maximal rate of
contraction
g.mm−2.s−1
Maximal rate of
relaxation
g.mm−2.s−1
N 1,8 ± 0,4 24 ± 4 15 ± 2
HH 1,8 ± 0,4 23 ± 4 16 ± 2
Values are means ± SE; n= 10 rats in each group (20 papillary muscles).
Fig. 5. Response to isoproterenol (ISO) of papillary muscles from normoxic (a) and HH
rats (b) in percentage increase of baseline values. Values are means ± SE. *P < 0,5 vs.
Control and L-NNA. DT: developed tension.
Table 3
Percentage of increase in basal rates of contraction and relaxation after β – adrenergic sti-
mulation.
Group Parameter Control L-arg L-NNA
Normoxia + T 77 ± 6 71 ± 4 70 ± 8
- T 135 ± 15 121 ± 14 128 ± 17
Hypobaric
hypoxia
+ T 65 ± 5 102 ± 14* 57 ± 5
- T 98 ± 12 142 ± 11* 103 ± 5
Values are means ± SE; *P < .05 vs. Control and L-NNA.
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experiment the sedentary life of the rats and the mild temperature
(22 °C) in the hypoxic chamber could have contributed to keep blood
pressure unchanged. Moreover, it was reported that during the first few
hours of exposure to hypoxia hypoxic vasodilation tends to override
sympathetic vasoconstriction in the systemic circulation, resulting in an
unchanged or slightly decreased systemic blood pressure [34,39].
4.2. Expression of HIF-1α, NOS and NO production
The expression of HIF-1α, which is recognized as the main regulator
of oxygen homeostasis in the body in response to hypoxia stimulus, was
found increased in this study. HIF regulates over 40 hypoxia-inducible
genes including NOS isoforms [1]. In our previous work we showed that
several weeks of exposure of initially immature rats to high altitude
increased the production and expression of NO in the mitochondrial
fraction [9,13], where NO regulates O2 consumption [24,40,41]. At a
systemic level, the main effect of NO is to bring up the peripheral va-
sodilation [3,42], promoting a better supply of oxygen to the tissues
[1]. In the pulmonary system, it functions to counterbalance the ten-
dency to develop pulmonary hypertension [43]. In the present study we
evaluated the cytosolic NOS system, finding a significant increase in the
expression of both constitutive isoforms, eNOS and nNOS, in left ven-
tricles of HH rats. The high increased levels in the expression of NOS
were not matched up by a similar equal level of NO production. This
would indicate a difference between the expression and the enzymatic
activation, which could be attributed to L-arg availability, Ca2+ tran-
sient and/or phosphorylation enzyme status [44,45]. The increased NO
level production has been also reported in other experimental models
and humans protocols, where NO modulates the degree of vasocon-
striction at systemic and pulmonary levels [46,47]. On the other hand
at mitochondrial level, the acute exposure to HH, would not be enough
to increase significantly the NOS expression as was previously found
after chronic hypoxia [9,13]. The slight increase observed in nNOS may
explain the decreased cytochrome oxidase activity in mitochondria
from hypoxic rats, since this effect was not evident in the presence of L-
NNA. In vivo, cytosolic NO would diffuse within the mitochondria en-
hancing the effect on cytochrome oxidase activity.
4.3. Basal contractile parameters
Excitation-contraction coupling is driven by an ion channel medi-
ated calcium cycle that produces myofilament contraction and relaxa-
tion, and NO synthesis by constitutive NOS is calcium dependent. The
effect of NO on contractility is bimodal in a concentration dependent
manner, and there are NOS isoform-specific responses within the heart
[9]. The action of the NOS depends on its systemic and intracellular
localization [1,3,14]. Inside papillary muscle NO modulates L-Ca+2 and
RyR channels directly by nitrosylation [14,23], modifying the levels of
intracellular Ca+2, which determine the contractile myofibrils stage
[48,49]. On the other hand, NO generated by mitochondrial NOS and/
or diffusing from cytosolic NOS, regulates oxygen consumption by the
Fig. 6. Mechanical response to 60 min of hypoxia and 30 min of reoxygenation expressed in percentage of prehypoxic developed tension (DT) of papillary muscles from (a) normoxic rats
and (b) rats submitted to hypobaric hypoxia, under maximal (L-arg), minimal (L-NNA), or control NO production. Values are means ± SE. ANOVA and Bonferroni were used for
comparisons between groups. *P < .05, HH Control and HH L-arg vs. all groups.
Table 4
Recovery of maximal rates of contraction (+T) and relaxation (-T) after 60 min H and
30 min R in percentage of prehypoxic values.
Group Parameter Control L-arg L-NNA
Normoxia + T 63 ± 5 59 ± 9 67 ± 5
- T 64 ± 5 60 ± 5 60 ± 6
Hypobaric
hypoxia
+ T 82 ± 6 80 ± 3 58 ± 2*
- T 82 ± 6 73 ± 3 56 ± 4*
Values are means ± SE; *P < .05 vs. Control and L-arg.
Fig. 7. Left ventricles belonging to 3mo old rats.
Microphotographs of (a) preserved tissue of a normoxic rat,
and (b) of a rat that was exposed to 48 h of hypobaric hy-
poxia, showing only slight morphologic changes such as
capillary congestion (arrow). The tissues were stained with
H&E (40X).
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respiratory mitochondrial chain [24,50] extending the space of ade-
quate tissue oxygenation away from the blood vessel [1]. These phy-
siological strategies would contribute to increase the contractile effi-
ciency (contractile function/oxygen consumption), preserving the
mechanical activity. Furthermore, no remarkable changes were found
in histological analysis of the hypoxic left ventricle except some evi-
dence of capillary congestion. After chronic hypoxia, an increase in NO
production and expression was associated to preservation of mechan-
ical activity from age-associated decline [2,9,13].
4.4. Mechanical β–adreneregic response
The absence of differential response to isoproterenol stimulus in
papillary muscles of normoxic animals after the addition of L-arg sub-
strate or of NOS blocker indicates no interaction between NOS and β-
adrenergic systems in a model without circulation or neuronal regula-
tion, in contrast with what was reported in perfused heart [18]. After
48 h of exposure to simulated high altitude (HHC), the response to β-
adrenergic stimulation remained the same as in normoxic muscles,
probably because of the unchanged β-adrenergic system during the first
hours of hypobaric treatment discussed above [34,39]. Conversely, L-
arg increased β-adrenergic response in HH papillary muscles. The in-
tracellular increase of Ca2+ by β-stimulation could activate the over-
expressed constitutive NOS, which is Ca2+ dependent. Such increased
NO production could nitrosylate L- Ca2+ and RyR channels [14,23],
improving mechanical activity.
4.5. Tolerance to hypoxia/reoxygenation
In the present study, under normoxic conditions, the tolerance to
acute H/R was low and was unaffected by the NOS system or by β
-adrenergic stimulation. The recovery of the contractile parameters was
similar to that found in our previous studies in normoxic rats (∼57%)
[2,9]. In agreement, the histological analysis revealed damage in the
papillary muscles supplemented with either L-arg or L-NNA (edema,
wavy myocardial fibers, and contraction bands), suggesting that the
NOS and the β-adrenergic systems were unable to improve resistance to
an H/R episode in normoxic animals. The discrepancy between these
findings and the cardioprotection conferred by β-adrenergic stimulation
observed by other authors [26,51] in normoxic rats could be attributed
to resistance to H/R of immature hearts [52,53]. Conversely, the high
level of NOS activity in the HH group would allow a good preservation
of the histological and mechanical conditions after acute H/R. The lack
of improvements in the HH L-NNA subgroup sustains the involvement
of NOS in the beneficial effects of acute exposure of rats to HH. The
produced NO would improve the tolerance to H/R, via modulation of
the mitochondrial transport chain and reduction of reactive oxygen
species generation [54]. Nitric oxide inhibits cytochrome oxidase re-
versibly and competitively with oxygen. The observed increment of
cytosolic NO levels as a consequences of higher expression of nNOS and
eNOS in the hypoxic conditions would inhibit cytochrome oxidase ac-
tivity, leaving oxygen available to diffuse and be used for other pro-
cesses. Furthermore, via S-nitrosylation, NO could attenuate a number
of adverse processes, such as apoptosis, inflammation, and opening of
the mitochondrial permeability transition pore, and even stimulate
protective processes like angiogenesis [25].
In conclusion, exposure of rats to acute hypobaric hypoxia increased
cytosolic NOS expression and NO production in left ventricle associated
to an improved tolerance of papillary muscles to hypoxia/reoxygena-
tion. These findings support the idea that it is possible to achieve en-
dogenous cardioprotection without changes in arterial pressure by
acute simulated high altitude exposure. This allows considering a pos-
sible preventive therapeutic approach for cardiovascular hypoxic risk
using short hypobaric hypoxia treatment or emulating the specific
molecular pathways involved.
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